ADAMTS13 and thrombotic thrombocytopenic purpura: After achieving remission, the prednisolone dose was tapered based on ADAMTS13 activity and inhibitor levels, starting from 0.5 mg/kg/day and decreasing by 5 mg per week while ensuring the absence of TTP recurrence.